Gary S. Stetz

Director & Interim CEO

Director & Interim CEO at Hepion Pharmaceuticals, Inc., filing insider transactions on 2026-08-03.

Total Purchases

$100K

1 transaction

Total Sales

—

0 transactions

Companies Traded

1 total filings

Active Since

2026-08-03

Last: 2026-08-03

Companies

Hepion Pharmaceuticals, Inc.

Date	Ticker	Type	Shares	Price	Value	Owned After
2026-08-03	HEPA	Purchase	2.00M	$0.05	$100K	3.25M	SEC ↗